Beijing Wantai Biological Pharmacy Enterprise Co Ltd Financial Flexibility Index
Beijing Wantai Biological Pharmacy Enterprise Co Ltd financial flexibility index. Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥252.80 Million (operating CF CN¥127.35 Million minus capex CN¥125.45 Million) represents 0% of total liabilities (CN¥2.10 Billion). Explore Beijing Wantai Biological Pharmacy Enter capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)
Financial flexibility index of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. Historical Financial Flexibility Index trend for Beijing Wantai Biological Pharmacy Enterprise Co Ltd across 13 annual periods. Check Beijing Wantai Biological Pharmacy Enter (603392) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Financial Flexibility Index by Year (2013–2025)
Beijing Wantai Biological Pharmacy Enterprise Co Ltd financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Beijing Wantai Biological Pharmacy Enterprise Co Ltd. For the full cash flow conversion analysis, see 603392 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥894.92 Million | CN¥89.75 Million | CN¥2.01 Billion | ▼ -19.7% |
| 2024 | 0.55x | CN¥1.24 Billion | CN¥355.08 Million | CN¥2.24 Billion | ▼ -43.2% |
| 2023 | 0.98x | CN¥2.76 Billion | CN¥1.60 Billion | CN¥2.83 Billion | ▼ -29.3% |
| 2022 | 1.38x | CN¥5.06 Billion | CN¥4.13 Billion | CN¥3.66 Billion | ▲ +25.7% |
| 2021 | 1.10x | CN¥2.73 Billion | CN¥1.68 Billion | CN¥2.48 Billion | ▲ +18.2% |
| 2020 | 0.93x | CN¥858.64 Million | CN¥468.21 Million | CN¥923.29 Million | ▲ +25.0% |
| 2019 | 0.74x | CN¥434.68 Million | CN¥272.68 Million | CN¥584.19 Million | ▼ -27.3% |
| 2018 | 1.02x | CN¥454.37 Million | CN¥208.31 Million | CN¥444.24 Million | ▲ +114.1% |
| 2017 | 0.48x | CN¥361.62 Million | CN¥146.97 Million | CN¥756.80 Million | ▼ -9.3% |
| 2016 | 0.53x | CN¥260.67 Million | CN¥129.40 Million | CN¥494.76 Million | ▼ -13.1% |
| 2015 | 0.61x | CN¥229.76 Million | CN¥151.84 Million | CN¥378.93 Million | ▼ -34.9% |
| 2014 | 0.93x | CN¥209.85 Million | CN¥132.43 Million | CN¥225.19 Million | ▲ +16.5% |
| 2013 | 0.80x | CN¥179.95 Million | CN¥97.83 Million | CN¥224.92 Million | — |